University of British Columbia

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1908-01-01

Employees: 10K

Market Cap: -

Website: http://www.ubc.ca

Clinical Trials

Evolocumab for PCSK9 Lowering in Early Acute Sepsis (The PLEASe Study)

Phase 2

Conditions: Sepsis

Interventions: Drug: Evolocumab
Drug: Placebo

First Posted Date: 2019-03-11

Last Posted Date: 2020-03-03

Lead Sponsor: University of British Columbia

Target Recruit Count: 36

Registration Number: NCT03869073

Locations: 🇨🇦
Surrey Memorial Hospital, Surrey, British Columbia, Canada
🇨🇦
Vancouver General Hospital, Vancouver, British Columbia, Canada
🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada

Virtual Reality vs. Standard-of-Care for Comfort During Dental Procedures in Children

Not Applicable

Conditions: Dental Procedures

Interventions: Device: Virtual Reality

First Posted Date: 2019-03-05

Last Posted Date: 2019-03-13

Lead Sponsor: University of British Columbia

Target Recruit Count: 64

Registration Number: NCT03862573

Locations: 🇨🇦
UBC graduate pediatric dentistry clinic, Vancouver, British Columbia, Canada

P.Acnes Colony Count Following Subdermal Cefazolin

Early Phase 1

Conditions: Microbial Colonization
Surgical Site Infection

Interventions: Drug: Cefazolin

First Posted Date: 2019-02-25

Last Posted Date: 2019-02-25

Lead Sponsor: University of British Columbia

Target Recruit Count: 20

Registration Number: NCT03853096

Ketone Supplementation, Glucose Control, and Cardiovascular Function

Not Applicable

Completed

Conditions: Overweight and Obesity
Diabetes Mellitus Risk
Hyperglycemia, Postprandial

Interventions: Dietary Supplement: Exogenous ketone monoester

First Posted Date: 2019-01-25

Last Posted Date: 2021-04-28

Lead Sponsor: University of British Columbia

Target Recruit Count: 15

Registration Number: NCT03817749

Locations: 🇨🇦
University of British Columbia, Okanagan., Kelowna, British Columbia, Canada

Caregivers' eCourse for Recovery After Hip Fracture

Not Applicable

Recruiting

Conditions: Hip Fractures
Family

Interventions: Behavioral: Caregivers eCourse

First Posted Date: 2019-01-24

Last Posted Date: 2024-10-18

Lead Sponsor: University of British Columbia

Target Recruit Count: 230

Registration Number: NCT03814928

Locations: 🇨🇦
UBC, Vancouver, Canada

A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine

Phase 1

Completed

Conditions: Migraine in Children
Posttraumatic Headache

Interventions: Drug: Lidocaine 2% Injectable Solution
Drug: Normal Saline Flush, 0.9% Injectable Solution

First Posted Date: 2019-01-16

Last Posted Date: 2021-04-28

Lead Sponsor: University of British Columbia

Target Recruit Count: 30

Registration Number: NCT03806595

Locations: 🇨🇦
BC Children's Hospital, Vancouver, British Columbia, Canada

Intra-nasal Dexmedetomidine for Children Undergoing MRI Imaging

Phase 4

Conditions: MRI Sedation

Interventions: Drug: Dexmedetomidine

First Posted Date: 2019-01-16

Last Posted Date: 2019-01-25

Lead Sponsor: University of British Columbia

Target Recruit Count: 180

Registration Number: NCT03806777

Skeletal Muscle Function in Interstitial Lung Disease

Not Applicable

Not yet recruiting

Conditions: Interstitial Lung Disease
Nonspecific Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis
Hypersensitivity Pneumonitis
Scleroderma

Interventions: Biological: Hyperoxia

First Posted Date: 2019-01-10

Last Posted Date: 2024-05-16

Lead Sponsor: University of British Columbia

Target Recruit Count: 40

Registration Number: NCT03800017

Relief From Side Effects: Clinical Use of Electrodes With Direction

Not Applicable

Conditions: Directional Lead
Deep Brain Stimulation
Essential Tremor

Interventions: Other: No side-effect stimulator settings with directional lead

First Posted Date: 2019-01-08

Last Posted Date: 2019-01-08

Lead Sponsor: University of British Columbia

Target Recruit Count: 6

Registration Number: NCT03795935

Locations: 🇨🇦
The Vancouver General Hospital, Vancouver, British Columbia, Canada

PET Study in Multiple Sclerosis

Conditions: Multiple Sclerosis

First Posted Date: 2018-12-26

Last Posted Date: 2019-04-22

Lead Sponsor: University of British Columbia

Target Recruit Count: 9

Registration Number: NCT03787446

Locations: 🇨🇦
UBC MS & NMO Clinical Trials Group, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy